Furukawa, Kenichiro
Hatakeyama, Keiichi
Terashima, Masanori http://orcid.org/0000-0002-2967-8267
Nagashima, Takeshi
Urakami, Kenichi
Ohshima, Keiichi
Notsu, Akifumi
Sugino, Takashi
Yagi, Taisuke
Fujiya, Keiichi
Kamiya, Satoshi
Hikage, Makoto
Tanizawa, Yutaka
Bando, Etsuro
Kanai, Yae
Akiyama, Yasuto
Yamaguchi, Ken
Article History
Received: 28 June 2021
Accepted: 23 August 2021
First Online: 2 September 2021
Declarations
:
: MT has received honorarium from Taiho Pharmaceutical Co. Ltd., Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Bristol Myers Squib Japan K.K., Yakult Honsha Co., Ltd, Takeda Pharmaceutical Co., Ltd, Eli Lilly Japan K.K., Pfizer Japan Inc., Daiichi Sankyo Ltd., Johnson and Johnson K.K., Medtronic Japan Co., Ltd., Intuitive Japan Inc., and Olympus Co., Ltd. EB has received honorarium from EIZO Corporation, TERUMO CORPORATION, and EIZAI.
: All procedures were conducted in accordance with the ethical standards of the corresponding committees on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. The institutional review board at Shizuoka Cancer Center approved all aspects of this study (authorization number 25-33). Informed consent was obtained from all patients.
Free to read: This content has been made available to all.